Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy

Not Applicable

Completed

Conditions: Infection

Interventions: Procedure: Transrectal MRI-guided prostate biopsy
Procedure: Transperineal MRI-guided prostate biopsy
Drug: Antibiotic (prophylaxis)

First Posted Date: 2021-04-13

Last Posted Date: 2025-04-15

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 687

Registration Number: NCT04843566

Locations: 🇺🇸
University of Connecticut, Farmington, Connecticut, United States
🇺🇸
University of Michigan Medical School, Ann Arbor, Michigan, United States
🇺🇸
Georgetown University, Washington, District of Columbia, United States

and more 7 locations

Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients

Phase 2

Terminated

Conditions: Myeloma
Myeloma Multiple
Refractory Multiple Myeloma

Interventions: Drug: Selinexor
Drug: Clarithromycin
Drug: Pomalidomide
Drug: Dexamethasone

First Posted Date: 2021-04-13

Last Posted Date: 2023-10-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 4

Registration Number: NCT04843579

Locations: 🇺🇸
Weill Cornell Medicine - Multiple Myeloma Center, New York, New York, United States
🇺🇸
NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

Not Applicable

Recruiting

Conditions: Infection

Interventions: Procedure: Transperineal MRI-guided prostate biopsy
Procedure: Transrectal MRI-guided prostate biopsy
Drug: Antibiotic (prophylaxis)

First Posted Date: 2021-03-25

Last Posted Date: 2024-04-12

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1302

Registration Number: NCT04815876

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
University of Southern California, Los Angeles, California, United States

and more 13 locations

Impact of Beta-blockers on Physical Function in HFpEF

Phase 4

Completed

Conditions: Heart Failure
Heart Failure, Diastolic
Heart Failure With Preserved Ejection Fraction
Cardiac Failure
Heart Disease

Interventions: Drug: Beta blockers

First Posted Date: 2021-02-23

Last Posted Date: 2023-09-08

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 9

Registration Number: NCT04767061

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF

Phase 4

Completed

Conditions: Heart Failure
Heart Failure, Diastolic
Heart Failure With Preserved Ejection Fraction
Cardiac Failure
Heart Disease

Interventions: Drug: Beta blockers

First Posted Date: 2021-02-17

Last Posted Date: 2024-04-09

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 9

Registration Number: NCT04757584

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Liver Transplantation for Unresectable Liver Limited Colorectal Metastases

Recruiting

Conditions: Unresectable Liver-limited Colorectal Metastases

First Posted Date: 2021-02-08

Last Posted Date: 2025-01-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT04742621

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

The Impact of Food Order on Glycemic Excursions in Type 2 Diabetes Assessed by Continuous Glucose Monitoring

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Behavioral: Carbohydrate-Last Meal Sequence
Behavioral: Carbohydrate-First Meal Sequence

First Posted Date: 2021-02-04

Last Posted Date: 2023-10-30

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT04738799

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Beta-blocker Administration for Cardiomyocyte Division

Phase 1

Recruiting

Conditions: Tetralogy of Fallot
Double Outlet Right Ventricle

Interventions: Other: N-thymidine
Other: Urine Collection
Procedure: Echocardiogram
Procedure: Cardiac MRI
Drug: Propranolol Hydrochloride
Drug: Placebo
Procedure: Physical Exam
Other: Specimen Collection

First Posted Date: 2021-01-19

Last Posted Date: 2024-08-07

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 40

Registration Number: NCT04713657

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
Upmc Children'S Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

Treatment of Early Hypertension Among Persons Living With HIV in Haiti

Phase 2

Completed

Conditions: HIV/AIDS
Pre Hypertension

Interventions: Drug: Amlodipine 5mg

First Posted Date: 2020-12-31

Last Posted Date: 2024-04-09

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 250

Registration Number: NCT04692467

Locations: 🇭🇹
GHESKIO, Port-au-Prince, Haiti

A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging

Phase 2

Recruiting

Conditions: Glioblastoma

Interventions: Other: Ketogenic Diet
Drug: Metformin

First Posted Date: 2020-12-31

Last Posted Date: 2025-01-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 36

Registration Number: NCT04691960

Locations: 🇺🇸
Columbia University, New York, New York, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy